Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma

Annals of Surgical Oncology

Volumn 21, Issue 4, 2014, Pages 640-647

  Sawada, Genta ^a,c   Takahashi, Yusuke ^a,c   Niida, Atsushi ^b   Shimamura, Teppei ^b   Kurashige, Junji ^a   Matsumura, Tae ^a,c   Ueo, Hiroki ^a   Uchi, Ryutaro ^a   Takano, Yuki ^a   Ueda, Masami ^a,c   Hirata, Hidenari ^a   Sakimura, Shotaro ^a   Shinden, Yoshiaki ^a   Eguchi, Hidetoshi ^a   Sudo, Tomoya ^a   Sugimachi, Keishi ^a   Miyano, Satoru ^b   Doki, Yuichiro ^c   Mori, Masaki ^c   Mimori, Koshi ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CDCP1 PROTEIN, HUMAN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; TUMOR PROTEIN;

AGED; CELL DIFFERENTIATION; CELL MOTION; ESOPHAGUS TUMOR; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL LINE; TUMOR INVASION;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE SILENCING; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE; TRANSFECTION;

EID: 84939887929     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3740-4     Document Type: Article

References (19)

1. Maehara Y, Orita H, Okuyama T, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg. 1992;79:245–7.
2. Kawamura YJ, Sakuragi M, Togashi K, Okada M, Nagai H, Konishi F. Distribution of lymph node metastasis in T1 sigmoid colon carcinoma: should we ligate the inferior mesenteric artery? Scand J Gastroenterol. 2005;40:858–61.
3. Goel HL, Languino LR. Integrin signaling in cancer. Cancer Treat Res. 2004;119:15–31.
4. Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev. 2010;29:223–37.
5. Spassov DS, Wong CH, Sergina N, et al. Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling. Mol Cell Biol. 2011;31:766–82.
6. Spassov DS, Wong CH, Wong SY, Reiter JF, Moasser MM. Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells. Cancer Res. 2013;73:1168–79.
7. Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol. 2007;27:7649–60.
8. Beroukhim R, Getz G, Nghiemphu L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA. 2007;104:20007–12.
9. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:R41.
10. Schafer M, Schwender H, Merk S, Haferlach C, Ickstadt K, Dugas M. Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. Bioinformatics. 2009;25:3228–35.
11. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.
12. Huebner K. Tumor suppressors on 3p: a neoclassic quartet. Proc Natl Acad Sci USA. 2001;98:14763–5.
13. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60:6116–33.
14. Bass AJ, Watanabe H, Mermel CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41:1238–42.
15. Scherl-Mostageer M, Sommergruber W, Abseher R, Hauptmann R, Ambros P, Schweifer N. Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene. 2001;20:4402–8.
16. Miyazawa Y, Uekita T, Hiraoka N, et al. CUB domain–containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res. 2010;70:5136–46.
17. Spassov DS, Wong CH, Harris G, et al. A tumor-suppressing function in the epithelial adhesion protein Trask. Oncogene. 2012;31:419–31.
18. Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS, Moasser MM. Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene. 2005;24:5333–43.
19. Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA. 2011;108:1379–84.